Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
116,964,738
-
Total 13F shares
-
37,510,462
-
Share change
-
+10,410,902
-
Total reported value
-
$793,275,948
-
Put/Call ratio
-
23%
-
Price per share
-
$21.15
-
Number of holders
-
109
-
Value change
-
+$210,973,219
-
Number of buys
-
71
-
Number of sells
-
50
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q1 2017
As of 31 Mar 2017,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,510,462 shares.
The largest 10 holders included
FMR LLC, Kohlberg Kravis Roberts & Co. L.P., BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, Partner Fund Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, CARLSON CAPITAL L P, STATE STREET CORP, and ORBIMED ADVISORS LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.